Evidence · Rigour · Impact
Eltanin Economics delivers expert health technology assessment and economic evaluation, grounded in scientific integrity and oriented toward actionable impact.
What We Do
We provide end-to-end economic evaluation across the full lifecycle of health technology assessment — from early economic evaluation to development of reimbursement models and everything in between.
Decision-analytic models built to CDA and NICE standards — Markov cohort, discrete event simulation, and individual patient-level models. Designed for reimbursement submissions and policy decisions.
Discuss your project →Full HTA support from evidence synthesis and systematic review through to dossier development. We work within Canadian, UK, and international frameworks with deep familiarity of payer expectations.
Discuss your project →Expert analysis of EQ-5D, SF-6D, HUI-2/3, AQoL, and 15D instruments — including mapping, linkage to administrative data, and mixed-methods quality-of-life measurement for clinical trials.
Discuss your project →Probabilistic sensitivity analysis, scenario analysis, and EVPI/EVPPI to characterise and communicate decision uncertainty. Tools and frameworks for robust HTA submissions and research prioritisation.
Discuss your project →A distinctive specialty: quantifying and incorporating the health economic burden on families and caregivers — critical for pediatric and rare disease evaluations where conventional models undercount total value.
Discuss your project →From study design and protocol development to health economics sections of grant applications. We support academic teams at every stage, including CIHR, HSFC, and PCORI-aligned submissions.
Discuss your project →Our Approach
We believe rigorous health economics is only valuable when it translates into decisions that hold up under scrutiny. That requires both technical precision and a clear-eyed understanding of the decision context.
Our work bridges academic depth and policy relevance — producing analyses that satisfy HTA reviewers and give decision-makers genuine confidence.
The Team
Eltanin Economics was founded to bring academic rigour to applied health economics consulting. We combine research excellence with practical decision-making experience.
Over 60 peer-reviewed publications and 30 funded research collaborations. Specialises in economic evaluation, HTA, and decision-analytic modelling across all healthcare disciplines.
Book a Meeting
Schedule a no-obligation introductory call to explore how Eltanin Economics can support your research, HTA submission, or grant application.
Select a time that works for you — the booking links directly to our calendar and you'll receive a confirmation immediately.
Get in Touch
Whether you're planning an HTA submission, designing a clinical trial's economic analysis, or writing a grant application — we'd be glad to discuss how we can help.
Contact Eltanin Economics